These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12963321)

  • 1. Current methods for the generation of human antibodies for the treatment of autoimmune diseases.
    Osbourn J; Jermutus L; Duncan A
    Drug Discov Today; 2003 Sep; 8(18):845-51. PubMed ID: 12963321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully human antibodies from transgenic mouse and phage display platforms.
    Lonberg N
    Curr Opin Immunol; 2008 Aug; 20(4):450-9. PubMed ID: 18606226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Next-Generation Techniques for Discovering Human Monoclonal Antibodies].
    Lushova AA; Biazrova MG; Prilipov AG; Sadykova GK; Kopylov TA; Filatov AV
    Mol Biol (Mosk); 2017; 51(6):899-906. PubMed ID: 29271955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development trends for human monoclonal antibody therapeutics.
    Nelson AL; Dhimolea E; Reichert JM
    Nat Rev Drug Discov; 2010 Oct; 9(10):767-74. PubMed ID: 20811384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of fully human monoclonal antibodies against human Orai1 for autoimmune disease.
    Lin FF; Elliott R; Colombero A; Gaida K; Kelley L; Moksa A; Ho SY; Bykova E; Wong M; Rathanaswami P; Hu S; Sullivan JK; Nguyen HQ; McBride HJ
    J Pharmacol Exp Ther; 2013 May; 345(2):225-38. PubMed ID: 23475901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage display for the production of human monoclonal antibodies against human pathogens.
    Mancini N; Carletti S; Perotti M; Canducci F; Mammarella M; Sampaolo M; Burioni R
    New Microbiol; 2004 Oct; 27(4):315-28. PubMed ID: 15646045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of therapeutic antibodies for the treatment of diseases.
    Lu RM; Hwang YC; Liu IJ; Lee CC; Tsai HZ; Li HJ; Wu HC
    J Biomed Sci; 2020 Jan; 27(1):1. PubMed ID: 31894001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of Recombinant Human Antibodies.
    Tomszak F; Weber S; Zantow J; Schirrmann T; Hust M; Frenzel A
    Adv Exp Med Biol; 2016; 917():23-54. PubMed ID: 27236551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles and application of antibody libraries for infectious diseases.
    Lim BN; Tye GJ; Choong YS; Ong EB; Ismail A; Lim TS
    Biotechnol Lett; 2014 Dec; 36(12):2381-92. PubMed ID: 25214212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibodies from transgenic mice.
    Lonberg N
    Handb Exp Pharmacol; 2008; 181(181):69-97. PubMed ID: 18071942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CD20 antibody for the treatment of systemic autoimmune diseases].
    Tanaka Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():728-33. PubMed ID: 15954437
    [No Abstract]   [Full Text] [Related]  

  • 12. A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells.
    Sasso E; Latino D; Froechlich G; Succoio M; Passariello M; De Lorenzo C; Nicosia A; Zambrano N
    MAbs; 2018 Jul; 10(5):730-737. PubMed ID: 29658818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
    Looney RJ
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibodies and therapeutics].
    Desgranges C
    Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for B-cell-targeted therapy in autoimmune disease.
    Edwards JC; Cambridge G
    Rheumatology (Oxford); 2005 Feb; 44(2):151-6. PubMed ID: 15509628
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease.
    Yazawa N; Hamaguchi Y; Poe JC; Tedder TF
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15178-83. PubMed ID: 16217038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage display-derived human antibodies in clinical development and therapy.
    Frenzel A; Schirrmann T; Hust M
    MAbs; 2016 Oct; 8(7):1177-1194. PubMed ID: 27416017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse opens door for study of autoimmune diseases.
    Check E
    Nature; 2004 Apr; 428(6985):786. PubMed ID: 15103338
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.
    Hernández P; Moreno E; Aira LE; Rodríguez PC
    Curr Drug Targets; 2016; 17(6):666-77. PubMed ID: 26844560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The autoimmune diseases manifested by production of autoantibodies: the autoantigens identified by random peptide library.
    Jadali Z; Sanati MH
    Iran J Allergy Asthma Immunol; 2008 Sep; 7(3):115-31. PubMed ID: 18780947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.